These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is videopupillography useful in the diagnosis of Alzheimer's disease? Ferrario E; Molaschi M; Villa L; Varetto O; Bogetto C; Nuzzi R Neurology; 1998 Mar; 50(3):642-4. PubMed ID: 9521249 [TBL] [Abstract][Full Text] [Related]
3. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease? Kurz A; Marquard R; Fremke S; Leipert KP Pharmacopsychiatry; 1997 Jan; 30(1):12-5. PubMed ID: 9065964 [TBL] [Abstract][Full Text] [Related]
9. Drop the Alzheimer's drop test. Kardon RH Neurology; 1998 Mar; 50(3):588-91. PubMed ID: 9521239 [No Abstract] [Full Text] [Related]
10. A potential noninvasive neurobiological test for Alzheimer's disease. Scinto LF; Daffner KR; Dressler D; Ransil BI; Rentz D; Weintraub S; Mesulam M; Potter H Science; 1994 Nov; 266(5187):1051-4. PubMed ID: 7973660 [TBL] [Abstract][Full Text] [Related]
11. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Graff-Radford NR; Lin SC; Brazis PW; Bolling JP; Liesegang TJ; Lucas JA; Uitti RJ; O'Brien PC Mayo Clin Proc; 1997 Jun; 72(6):495-504. PubMed ID: 9179132 [TBL] [Abstract][Full Text] [Related]
12. Possible new test found for Alzheimer's disease. Barinaga M Science; 1994 Nov; 266(5187):973. PubMed ID: 7973680 [No Abstract] [Full Text] [Related]
13. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia. Robles A; Touriño R; Gude F; Noya M Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893 [TBL] [Abstract][Full Text] [Related]
14. Pupillary response to topical tropicamide as a marker for Alzheimer's disease. Treloar AJ; Assin M; Macdonald AJ Br J Clin Pharmacol; 1996 Mar; 41(3):256-7. PubMed ID: 8866930 [TBL] [Abstract][Full Text] [Related]
15. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease. Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon 4 allele and pupillary response to tropicamide. Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H; Hayashida M Am J Psychiatry; 1997 May; 154(5):694-6. PubMed ID: 9137131 [TBL] [Abstract][Full Text] [Related]
17. Pupil assay and Alzheimer's disease: a critical analysis. Scinto LF; Rentz DM; Potter H; Daffner KR Neurology; 1999 Feb; 52(3):673-4. PubMed ID: 10025819 [No Abstract] [Full Text] [Related]
18. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171 [TBL] [Abstract][Full Text] [Related]